Biotech Fund Doubles Down: Scholar Rock Bet Drives 26% Rally
A major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
This intro covers the worst drawdowns seen in SP 500 index funds, explaining factors behind steep declines and the recovery path.
15,257 articlesA major biotech fund has increased its stake in Scholar Rock, increasing exposure to a platform that targets protein ...
Quantum computing could redefine Bitcoin security. Glassnode highlights exchange-held coins as a critical vulnerabili...
As rates stay elevated amid market turbulence, three preferred stock ETFs are emerging as ballast for retirement port...
A court decision upends White House tariff policy, leaving $175 billion in IEEPA duties in limbo. The Treasury secret...
A major move by a wealth manager can ripple through markets and tax strategies. Discover what truewealth exits $12.8 ...
A viral online persona hid a troubling reality: a calculated scheme built on a bogus cancer crisis. Learn the red fla...
The Trump administration has paused $259.5 million in Minnesota's Medicaid funding amid fraud concerns, demanding a c...
A high-profile case highlights how private money moves can affect finances and risk. This article breaks down what yo...
Investors are weighing where will spacex stock go over the next 12 months. This guide breaks down the drivers, scenar...
Federal investigators have seized over $61 million in USDT linked to romance scam operations, tracing the funds throu...
Two popular aerospace ETFs, XAR and ITA, offer different paths to exposure in a sector shaped by defense spending and...
A district tax office confrontation reveals how cash payments can slip through cracks. Explore what happened, how to ...